terazosin
- Product NDC
- 70518-3193
- 11-digit product format
- 705183193
- Labeler code
- 70518
- Product ID
- 70518-3193_52411136-a429-53dd-e063-6394a90ac304
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA075614
- Marketing category
- ANDA
- Marketing start
- 2021-08-12
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- terazosin
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 313215 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-3193-0 | terazosin | 30 in 1 BLISTER PACK | CAPSULE | 30 | | 7 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-3193 | TERAZOSIN CAPSULE [REMEDYREPACK INC.] | 3 | Current NDC, Legacy NDC, 1 package rows | 20240315_77e01f71-f6d8-4bbe-b13e-352c7af6b1ef.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3193-0 | 70518319300 | 30 CAPSULE in 1 BLISTER PACK (70518-3193-0) | 30 capsule | 2021-08-12 | 0000-00-00 | No | No | Current |